Combined high and low dosing of OKT3 for treatment of rejection episodes in renal transplants

Transplant Proc. 1994 Dec;26(6):3141.

Authors

R T Schweizer¹, S Bartus, D Hull, G Perdrizet, L Roper

Affiliation

¹ Hartford Transplant Center, Hartford Hospital, Connecticut 06102-5037.

PMID: 7998094

No abstract available

Publication types

Clinical Trial
Comparative Study
Controlled Clinical Trial

MeSH terms

Cyclosporine / therapeutic use
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Graft Rejection / therapy*
Graft Survival
Humans
Kidney Transplantation / immunology*
Methylprednisolone / therapeutic use
Muromonab-CD3 / therapeutic use*
Survival Rate
Time Factors

Substances

Muromonab-CD3
Cyclosporine
Methylprednisolone